Platinum Sponsor
PolyPeptide Group
Profile
PolyPeptide is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India with around 1,200 employees as per the middle of 2022. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
We're bringing you
Peptide-Oligonucleotides Conjugates from a CDMO Perspective
, 2:30pmView SessionNetworking Cocktail Reception with Poster and Exhibit Viewing
, 5:30pmView SessionControl Strategy Set-Up for Efficient & Safe Large Scale Peptide Manufacturing Process
, 2:05pmView Session